Notably, overweight patients exhibited accentuated GPD1L downregulation (Figure 3b), aligning with preclinical models demonstrating diet-induced obesity reduces hepatic GPD1L expression by 63% (P<0.001) (11), suggesting a potential mechanism for obesity-associated CRC progression. Here, GPD1L is linked to obesity disorder.